Infographic: Highlights of Cronos’ (CRON) Q4 2021 earnings report 4 years ago Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit… JPMorgan Chase (JPM) CEO Jamie Dimon’s Letter to Shareholders: Key Points 4 years ago In his letter to shareholders, CEO Jamie Dimon said that JPMorgan Chase will do its part to ensure the global… Infographic: How Tilray (TLRY) performed in Q3 2022 4 years ago Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23%… Infographic: Highlights of J.M. Smucker’s (SJM) Q3 2022 earnings report 4 years ago The JM Smucker Company (NYSE: SJM) has reported lower earnings and net sales for the third quarter of 2022, reflecting… Take-Two Interactive (TTWO): Three factors that bode well for the gaming company 4 years ago Shares of Take-Two Interactive Software Inc. (NASDAQ: TTWO) were up over 1% on Monday. The stock has dropped 13% year-to-date… R&D will be a cornerstone to the future success of Semantix: CEO Leonardo Santos 4 years ago Semantix is a leading data software platform having strong presence across the Americas. Founded in 2010, the Brazil-based company provides… Mobileye IPO: Why the spin-off is significant for Intel (INTC) 4 years ago After several weeks of muted IPO activity, Wall Street is getting ready for probably a blockbuster listing that is expected… Delta Air Lines (DAL): A look at the airline’s expectations for the coming quarter and year 4 years ago Shares of Delta Air Lines Inc. (NYSE: DAL) have gained 13% over the past one month. After a tough two… Infographic: Highlights of Expedia’s (EXPE) Q4 2021 earnings 4 years ago Expedia Group (NASDAQ: EXPE) recently reported its fourth-quarter 2021 financial results. The travel company’s revenues more than doubled year-over-year to $2.3… Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu 4 years ago Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is… Next» « Previous